Published in
American Society for Clinical Investigation, Journal of Clinical Investigation, 13(132), 2022
DOI: 10.1172/jci145099
Links
Tools
Deficiency of the splicing factor RBM10 limits EGFR inhibitor response in EGFR mutant lung cancer
Journal article published in 2022 by
Shigeki Nanjo 
,
Wei Wu ,
Niki Karachaliou,
Collin M. Blakely,
Junji Suzuki ,
Yu-Ting Chou,
Siraj M. Ali ,
D. Lucas Kerr ,
Victor R. Olivas,
Jonathan Shue,
Julia Rotow,
Manasi K. Mayekar,
Franziska Haderk ,
Nilanjana Chatterjee ,
Anatoly Urisman
and other authors.
,
Wei Wu ,
Niki Karachaliou,
Collin M. Blakely,
Junji Suzuki ,
Yu-Ting Chou,
Siraj M. Ali ,
D. Lucas Kerr ,
Victor R. Olivas,
Jonathan Shue,
Julia Rotow,
Manasi K. Mayekar,
Franziska Haderk ,
Nilanjana Chatterjee ,
Anatoly Urisman
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Postprint:
archiving forbidden
Data provided by 